JPH05503510A - 光学的に純粋な（ｓ）―アテノロールを含む組成物と方法 - Google Patents

光学的に純粋な（ｓ）―アテノロールを含む組成物と方法

Info

Publication number
JPH05503510A
JPH05503510A JP3501087A JP50108791A JPH05503510A JP H05503510 A JPH05503510 A JP H05503510A JP 3501087 A JP3501087 A JP 3501087A JP 50108791 A JP50108791 A JP 50108791A JP H05503510 A JPH05503510 A JP H05503510A
Authority
JP
Japan
Prior art keywords
atenolol
beta
drug
drugs
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP3501087A
Other languages
English (en)
Japanese (ja)
Inventor
バーブリツチ，チモシー・ジエイ
ブラツツラー，ロバート・エル
ヤング，ジエイムズ・ダブリユー
ルイス，ウイリアム・ジエイ
Original Assignee
セプラカー・インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セプラカー・インコーポレーテツド filed Critical セプラカー・インコーポレーテツド
Publication of JPH05503510A publication Critical patent/JPH05503510A/ja
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP3501087A 1989-11-21 1990-11-21 光学的に純粋な（ｓ）―アテノロールを含む組成物と方法 Expired - Lifetime JPH05503510A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44003689A 1989-11-21 1989-11-21
US440,036 1989-11-21

Publications (1)

Publication Number Publication Date
JPH05503510A true JPH05503510A (ja) 1993-06-10

Family

ID=23747155

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3501087A Expired - Lifetime JPH05503510A (ja) 1989-11-21 1990-11-21 光学的に純粋な（ｓ）―アテノロールを含む組成物と方法

Country Status (5)

Country Link
EP (1) EP0519925A1 (fr)
JP (1) JPH05503510A (fr)
AU (1) AU643487B2 (fr)
CA (1) CA2069404A1 (fr)
WO (1) WO1991007175A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009191069A (ja) * 2008-02-14 2009-08-27 Lab Servier 洞房結節Ｉｆ電流阻害剤とβブロッカーとの組み合わせ

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000074A1 (fr) * 1991-06-26 1993-01-07 Sepracor, Inc. Methodes et compositions pour le traitement des vomissements, de la nausee et d'autres troubles faisant appel a l'ondansetron optiquement pur r(+)
EP1262182A3 (fr) * 1991-11-26 2003-02-26 Sepracor Inc. Procédés et compositions destinés à traiter l'hypertension, l'angine de poitrine et d'autres troubles à l'aide de (-) amlodipine optiquement pure
ATE457169T1 (de) * 1998-10-15 2010-02-15 Imp Innovations Ltd Verbindungen für die behandlung von gewichtsverlust
WO2000051582A2 (fr) 1999-03-01 2000-09-08 Sepracor Inc. Procedes de traitement de l'apnee et de troubles de l'apnee a l'aide de r(+) ondansetron optiquement pur

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62245353A (ja) * 1986-04-18 1987-10-26 Hitachi Ltd Ｅｅｐｒｏｍのデ−タ書換え防止回路
JPS62271031A (ja) * 1986-05-20 1987-11-25 Fujitsu Ltd 記憶デ−タ保護方式

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8618324D0 (en) * 1986-07-28 1986-09-03 Shell Int Research Phenylacetate/atenolol

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62245353A (ja) * 1986-04-18 1987-10-26 Hitachi Ltd Ｅｅｐｒｏｍのデ−タ書換え防止回路
JPS62271031A (ja) * 1986-05-20 1987-11-25 Fujitsu Ltd 記憶デ−タ保護方式

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009191069A (ja) * 2008-02-14 2009-08-27 Lab Servier 洞房結節Ｉｆ電流阻害剤とβブロッカーとの組み合わせ
JP2012211179A (ja) * 2008-02-14 2012-11-01 Lab Servier 洞房結節Ｉｆ電流阻害剤とβブロッカーとの組み合わせ

Also Published As

Publication number Publication date
WO1991007175A1 (fr) 1991-05-30
AU643487B2 (en) 1993-11-18
EP0519925A1 (fr) 1992-12-30
AU6893391A (en) 1991-06-13
CA2069404A1 (fr) 1991-05-22

Similar Documents

Publication Publication Date Title
US5556870A (en) Use of leflunomide for inhibiting interleukin 1 beta
JPH04502161A (ja) 緑内障の治療処置におけるアセチルｄ―カルニチンの用途
JP2930245B2 (ja) １，２，３，４―テトラヒドロ―９―アクリジナミンの誘導体
JPS62212322A (ja) 医薬組成物および処置法
WO2020107500A1 (fr) Sel de 2-(1)-acyloxypentyl) acide benzoïque formé par un acide aminé basique ou aminoguanidine, son procédé de préparation et ses applications
JPH0469377A (ja) ジフェニルメチルピペラジン誘導体
JPS61254524A (ja) 抗血栓形成性医薬組成物
US6399658B1 (en) Composition containing ascorbic acid
CN115304593B (zh) 苯并异噻唑化合物及其药物组合物和应用
JPH05503510A (ja) 光学的に純粋な（ｓ）―アテノロールを含む組成物と方法
US4237165A (en) Treatment of carbohydrate metabolism disorders
TW200940543A (en) Maleate, besylate and L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
JPH03503162A (ja) 化学療法における毒性特性の改良
US4851414A (en) Anti-dementia agent
CN1128999A (zh) 杂环化合物
CN100441589C (zh) 含水溶性基团的葛根素化合物及其制法和用途
JPS61500437A (ja) ｎ−プロパノ−ルアミン誘導体のエ−テル
US4439442A (en) Naftidrofuryl citrate and therapeutic applications
EP0594867A1 (fr) Agent de stimulation de la production de somatostatine ou d'inhibition de la diminution de la production de cette substance
EP0263208A2 (fr) Utilisation anti-arhythmique des aminocycloalkylamides
EP0103897B1 (fr) Composition pharmaceutique utile pour l'amélioration ou le traitement des symptômes mentaux causés par des désordres organiques dans le cerveau
JPH0138089B2 (fr)
JPH04507246A (ja) アニパミールの（＋）―エナンチオマーの使用
CN120420312A (zh) 苄基苯基醚类化合物的用途
US4786634A (en) Method for treating arteriosclerosis

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090327

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100327

Year of fee payment: 14

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100327

Year of fee payment: 14